Systemic lupus erythematosus and ethnicity: Nature versus nurture or nature and nurture?

Expert Review of Clinical Immunology

Volumn 3, Issue 4, 2007, Pages 589-601

  Calvo Alén, Jaime ^a   Alarcón, Graciela S ^b  

^a HOSPITAL SIERRALLANA   (Spain)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; HLA DR ANTIGEN; HLA DR2 ANTIGEN; HLA DR3 ANTIGEN;

AFRICAN AMERICAN; CAUCASIAN; CLINICAL FEATURE; CULTURAL FACTOR; DEMOGRAPHY; DISEASE ACTIVITY; DISEASE COURSE; ETHNICITY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HISPANIC; HUMAN; INCIDENCE; LUPUS ERYTHEMATOSUS NEPHRITIS; MORTALITY; POPULATION GENETICS; PREVALENCE; PROGNOSIS; RACE DIFFERENCE; REVIEW; RISK FACTOR; SOCIOECONOMICS; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 34447649028     PISSN: 1744666X     EISSN: None     Source Type: Journal    
DOI: 10.1586/1744666X.3.4.589     Document Type: Review

References (138)

1. Reveille JD, Moulds JM, Ahn C et al. Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in Minority Populations: Nature Versus Nurture. Arthritis Rheum. 41(7), 1161-1172 (1998).
2. Alarcon GS, Roseman J, Bartolucci AA et al. Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. LUMINA Study Group. Lupus in Minority Populations: Nature Versus Nurture. Arthritis Rheum. 41(7), 1173-1180 (1998).
3. Fessel WJ. Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women. Arch. Intern. Med. 134(6), 1027-1035 (1974).
4. Reveille JD, Bartolucci A, Alarcon GS. Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum. 33(1), 37-48 (1990).
5. Alarcon GS, Friedman AW, Straaton KV et al. Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. Lupus in Minority Populations: Nature Versus Nurture. Lupus 8(3), 197-209 (1999).
6. Nossent JC. Systemic lupus erythematosus on the Caribbean island of Curacao: an epidemiological investigation. Ann. Rheum. Dis. 51 (11), 1197-1201 (1992).
7. Thumboo J, Uramoto K, O'Fallon WM et al. A comparative study of the clinical manifestations of systemic lupus erythematosus in Caucasians in Rochester, Minnesota, and Chinese in Singapore, from 1980 to 1992. Arthritis Rheum. 45(6), 494-500 (2001).
8. Frank AO. Apparent predisposition to systemic lupus erythematosus in Chinese patients in West Malaysia. Ann. Rheum. Dis. 39(3), 266-269 (1980).
9. Samanta A, Feehally J, Roy S et al. High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. Ann. Rheum. Dis. 50(7), 490-492 (1991).
10. Serdula MK, Rhoads GG. Frequency of systemic lupus erythematosus in different ethnic groups in Hawaii. Arthritis Rheum. 22(4), 328-333 (1979).
11. Segasothy M, Phillips PA. Systemic lupus erythematosus in Aborigines and Caucasians in central Australia: a comparative study. Lupus 10(6), 439-444 (2001).
12. Molokhia M, McKeigue PM, Cuadrado M, Hughes G. Systemic lupus erythematosus in migrants from west Africa compared with Afro - Caribbean people in the UK. Lancet 357(9266), 1414-1415 (2001).
13. Bae SC, Fraser P, Liang MH. The epidemiology of systemic lupus erythematosus in populations of African ancestry: a critical review of the "prevalence gradient hypothesis". Arthritis Rheum. 41(12), 2091-2099 (1998).
14. Molina JF, Molina J, Garcia C et al. Ethnic differences in the clinical expression of systemic lupus erythematosus: a comparative study between African - Americans and Latin Americans. Lupus 6(1), 63-67 (1997).
15. Gioud-Paquet M, Chamot AM, Bourgeois P, Meyer O, Kahn MF. Symptomatic and prognostic differences according to ethnic group in systemic lupus erythematosus. A controlled study of 3 populations. Presse Med. 17(3), 103-106 (1988).
16. Cooper RS, Kaufman JS, Ward R. Race and genomics. N. Engl. J. Med. 348 (12), 1166-1170 (2003).
17. Alarcon GS. Of ethnicity, race and lupus. Lupus 10(9), 594-596 (2001).
18. McKenzie KJ, Crowcroft NS. Race, ethnicity. culture, and science. Br. Med. J. 309(6950), 286-287 (1994).
19. McKenzie K, Crowcroft NS. Describing race, ethnicity, and culture in medical research. Br. Med. J. 312(7038), 1054 (1996).
20. Burchard EG, Ziv E, Coyle N et al. The importance of race and ethnic background in biomedical research and clinical practice. N. Engl. J. Med. 348(12),1170-1175 (2003).
21. Escalante A, Espinosa-Morales R, del Rincon I, Arroyo RA, Older SA. Recipients of hip replacement for arthritis are less likely to be Hispanic, independent of access to health care and socioeconomic status. Arthritis Rheum. 43(2), 390-399 (2000).
22. Risch N. Dissecting racial and ethnic differences. N. Engl. J. Med. 354(4), 408-411 (2006).
23. Krishnan E, Hubert HB. Ethnicity and mortality from systemic lupus erythematosus in the US. Ann. Rheum. Dis. 65(11), 1500-1505(2006).
24. Wandstrat A, Wakeland E. The genetics of complex autoimmune diseases: non-MHC susceptibility genes. Nat. Immunol. 2(9), 802-809 (2001).
25. Sestak AL, Nath SK, Harley JB. Genetics of systemic lupus erythematosus: how far have we come? Rheum. Dis. Clin. North Am. 31(2), 223-244, v (2005).
26. Croker JA, Kimberly RP. Genetics of susceptibility and severity in systemic lupus erythematosus. Curr. Opin. Rheumatol. 17(5), 529-537 (2005).
27. Tan FK, Arnett FC. The genetics of lupus. Curr. Opin. Rheumatol 10(5), 399-408 (1998).
28. Reveille J. MHC class II and non-MHC genes in the pathogenesis ofsystemic lupus erythematosus. In: Systemic Lupus Erythematosus. Lahita R (Ed.). Elsevier, Academic Press, CA, USA 109-151 (2004).
29. Harley JB, Moser KL, Gaffney PM, Behrens TW. The genetics of human systemic lupus erythematosus. Cum Opin. Immunol. 10(6), 690-696(1998).
30. Calvo-Alen J, Reveille JD, Rodriguez-Valverde V et al. Clinical, immunogenetic and outcome features of Hispanic systemic lupus erythematosus patients of different ethnic ancestry. Lupus 12(5), 377-385 (2003).
31. Sullivan KE. Genetics of systemic lupus erythematosus. Clinical implications. Rheum. Dis. Clin. North Am. 26(2), 229-256, v-vi (2000).
32. Tsao BP. The genetics of human lupus. In: Dubois' Lupus Erythematosus. Wallace DJ, Hahn BH (Eds). Lippincot Williams & Wilkins, PA, USA 97-119 (2002).
33. Garred P, Voss A, Madsen HO, Junker P. Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients. Genes Immun. 2(8),442-450 (2001).
34. Lau YL, Lau CS, Chan SY, Karlberg J, Turner MW. Mannose-binding protein in Chinese patients with systemic lupus; erythematosus. Arthritis Rheum. 39(4), 706-708 (1996).
35. Sullivan KE, Wooten C, Goldman D, Petri M. Mannose-binding protein genetic polymorphisms in black patients with systemic lupus erythematosus. Arthritis Rheum. 39(12), 2046-2051 (1996).
36. Davies EJ, Teh LS, Ordi-Ros J et al. A dysfunctional allele of the mannose binding protein gene associates with systemic lupus erythematosus in a Spanish population. J. Rheumatol. 24(3), 485-488 (1997).
37. Villarreal J, Crosdale D, Ollier W et al. Mannose binding lectin and FcγyRIIa (CD32) polymorphism in Spanish systemic lupus erythematosus patients. Rheumatology (Oxf.) 40(9), 1009-1012 (2001).
38. Huang YF, Wang W, Han JY et al. Increased frequency of the mannose-binding lectin LX haplotype in Chinese systemic lupus erythematosus patients. Eur. J. Immunogenet. 30(2), 121-124 (2003).
39. Tsutsumi A, Sasaki K, Wakamiya N et al. Mannose-binding lectin gene: polymorphisms in Japanese patients with systemic lupus erythematosus, rheumatoid arthritis and Sjogren's syndrome. Genes Immun. 2(2), 99-104 (2001).
40. Ip WK, Chan SY, Lau CS, Lau YL. Association of systemic lupus erythematosus with promoter polymorphisms of the mannose-binding lectin gene. Arthritis Rheum. 41(9), 1663-1668 (1998).
41. Sinha M, Larkin EK, Elston RC, Redline S. Self-reported race and genetic admixture. N. Engl. J. Med. 354(4), 421-422 (2006).
42. Alarcon GS, Beasley TM, Roseman JM et al. Ethnic disparities in health and disease: the need to account for ancestral admixture when estimating the genetic contribution to both (LUMINA XXVI). Lupus 14(10), 867-868 (2005).
43. Mitchell BD, Williams-Blangero S, Chakraborty R et al. A comparison of three methods for assessing Amerindian admixture in Mexican Americans. Ethn. Dis. 3(1), 22-31 (1993).
44. Shaw SJ, Vadheim CM, Rotter JI et al. Ancestral origin of insulin-dependent diabetes in Mexican-Americans. Int. J. Epidemiol. 21(4), 725-729 (1992).
45. Byard PJ, Lees FC. Estimating the number of loci determining skin colour in a hybrid population. Ann. Hum. Biol. 8(1), 49-58 (1981).
46. Reitnauer PJ, Go RC, Acton RT et al. Evidence for genetic admixture as a determinant in the occurrence of insulin-dependent diabetes mellitus in U.S. blacks. Diabetes 31(6 Pt 1), 532-537 (1982).
47. McKeigue PM, Carpenter JR, Parra EJ, Shriver MD. Estimation of admixture and detection of linkage in admixed populations by a Bayesian approach: application to African-American populations. Ann. Hum. Genet. 64(Pt 2), 171-186 (2000).
48. Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. Genetics 155 (2), 945-959(2000).
49. Molokhia M, Hoggart C, Patrick AL et al. Relation of risk of systemic lupus erythematosus to West African admixture in a Caribbean population. Hum. Genet. 112(3), 310-318 (2003).
50. McKeigue PM. Prospects for admixture mapping of complex traits. Am. J. Hum. Genet. 76(1), 1-7 (2005).
51. Rus V, Hochberg M. The epidemiology of systemic lupus erythematosus. In: Dubois' Lupus Erythematosus. Wallace D, Hahn B (Eds). Lippincott Williams & Wilkins, PA, USA 65-83 (2002).
52. Siegel M, Lee SL. The epidemiology of systemic lupus erythematosus. Semin. Arthritis Rheum. 3(1), 1-54 (1973).
53. McCarthy DJ, Manzi S, Medsger TA Jr et al. Incidence of systemic hipus erythematosus. Race and gender differences. Arthritis Rheum. 38(9), 1260-1270 (1995).
54. Johnson AE, Gordon C, Palmer RG, Bacon PA. The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth. Arthritis Rheum. 38(4), 551-558 (1995).
55. Hopkinson ND, Doherty M, Powell RJ. The prevalence and incidence of systemic lupus erythematosus in Nottingham, UK, 1989-1990. Br. J. Rheumatol. 32(2), 110-115 (1993).
56. Hopkinson ND, Doherty M, Powell RJ. Clinical features and race-specific incidence/prevalence rates of systemic lupus erythematosus in a geographically complete cohort of patients. Ann. Rheum. Dis. 53(10), 675-680 (1994).
57. Polednak AP. Connective tissue responses in blacks in relation to disease: further observations. Am. J. Phys. Anthropol. 74(3), 357-371 (1987).
58. Hochberg MC. The incidence of systemic lupus erythematosus in Baltimore, Maryland, 1970-1977. Arthritis Rheum. 28(1), 80-86 (1985).
59. Wilson WA, Hughes GR. Rheumatic disease in Jamaica. Ann. Rheum. Dis. 38(4), 320-325 (1979).
60. Morton RO, Gershwin ME, Brady C, Steinberg AD. The incidence of systemic lupus erythematosus in North American Indians. J. Rheumatol. 3(2), 186-190 (1976).
61. Atkins C, Reuffel L, Roddy J et al. Rheumatic disease in the Nuu-Chah-Nulth native Indians of the Pacific Northwest. J. Rheumatol. 15(4), 684-690 (1988).
62. Boyer GS, Templin DW, Lanier AP. Rheumatic diseases in Alaskan Indians of the southeast coast: high prevalence of rheumatoid arthritis and systemic lupus erythematosus. J. Rheumatol. 18(10), 1477-1484 (1991).
63. Samanta A, Roy S, Feehally J, Symmons DP. The prevalence of diagnosed systemic lupus erythematosus in whites and Indian Asian immigrants in Leicester city, UK. Br. J. Rheumatol. 31(10), 679-682 (1992).
64. Hart HH, Grigor RR, Caughey DE. Ethnic difference in the prevalence of systemic lupus erythematosus. Ann. Rbeum. Dis. 42(5), 529-532 (1983).
65. Anstey NM, Bastian I, Dunckley H, Currie BJ. Systemic lupus erythematosus in Australian aborigines: high prevalence, morbidity and mortality. Aust. NZ J. Med. 23(6), 646-651 (1993).
66. Nai-Zheng C. Rheumatic diseases in China. J. Rheumatol. 10 (Suppl. 10), 41-44 (1992).
67. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 35(6), 630-640 (1992).
68. Liang MH, Socher SA, Roberts WN, Esdaile JM. Measurement of systemic lupus erythematosus activity in clinical research. Arthritis Rheum. 31(7), 817-825 (1988).
69. Symmons DP, Coppock JS, Bacon PA et al. Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. Members of the British Isles Lupus Assessment Group (BILAG). Q. J. Med. 69(259), 927-937 (1988).
70. Gladman D, Ginzler E, Goldsmith C et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 39(3), 363-369 (1996).
71. Perez-Gutthann S, Petri M, Hochberg MC. Comparison of different methods of classifying patients with systemic lupus erythematosus. J. Rheumatol. 18(8), 1176-1179 (1991).
72. Abu-Shakra M, Gladman DD, Urowitz MB. Malignancy in systemic lupus erythematosus. Arthritis Rheum. 39(6), 1050-1054 (1996).
73. Cooper GS, Parks CG, Treadwell EL et al. Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States. Lupus 11 (3), 161-167 (2002).
74. Alarcon GS, McGwin G Jr, Petri M et al. Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus 11 (2), 95-101 (2002).
75. Pons-Estel BA, Catoggio LJ, Cardiel MH et al. The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among "Hispanics". Medicine (Balt.) 83(1), 1-17 (2004).
76. Nossent JC. SLICC/ACR Damage Index in Afro - Caribbean patients with systemic lupus erythematosus: changes in and relationship to disease activity, corticosteroid therapy, and prognosis. J. Rheumatol. 25(4), 654-659 (1998).
77. Alarcon GS, McGwin G Jr., Bartolucci AA et al. Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual. Arthritis Rheum. 44(12), 2797-2806(2001).
78. Alarcon GS, Roseman JM, McGwin G Jr et al. Systemic lupus erythematosus in three ethnic groups. XX, Damage as a predictor of further damage. Rheumatology (Oxf.) 43(2), 202-205 (2004).
79. Cook RJ, Gladman DD, Pericak D, Urowitz MB. Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity. J. Rheumatol. 27(8), 1892-1895 (2000).
80. Ibanez D, Gladman DD, Urowitz MB. Adjusted mean Systemic Lupus Erythematosus Disease Activity Index-2K is a predictor of outcome in SLE. J. Rheumatol. 32(5), 824-827 (2005).
81. Stoll T, Sutcliffe N, Mach J, Klaghofer R, Isenberg DA. Analysis of the relationship between disease activity and damage in patients with systemic lupus erythematosus - a 5-yr prospective study. Rheumatology (Oxf.) 43(8), 1039-1044 (2004).
82. Alarcon GS, McGwin G Jr, Bastian HM et al. Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group. Arthritis Rheum. 45(2), 191-202 (2001).
83. Hernandez-Cruz B, Tapia N, Villa-Romero AR, Reyes E, Cardiel MH. Risk factors associated with mortality in systemic lupus erythematosus. A case-control study in a tertiary care center in Mexico City. Clin. Exp. Rheumatol. 19(4), 395-401 (2001).
84. Petri M, Perez-Gutthann S, Longenecker JC, Hochberg M. Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Am. J. Med. 91(4), 345-353 (1991).
85. Karlson EW, Daltroy LH, Lew RA et al. The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum. 40(1), 47-56 (1997).
86. Karlson EW, Daltroy LH, Lew RA et al.. The independence and stability of socioeconomic predictors of morbidity in systemic lupus erythematosus. Arthritis Rheum. 38(2), 267-273 (1995).
87. Alarcon GS, Calvo-Alen J, McGwin G Jr et al. Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time. Ann. Rheum. Dis. 65(9), 1168-1174 (2006).
88. Austin HA, 3rd, Boumpas DT, Vaughan EM, Balow JE. High-risk features of lupus nephritis: importance of race and clinical and histological factors in 166 patients. Nephrol. Dial. Transplant. 10(9), 1620-1628 (1995).
89. Dooley MA, Hogan S, Jennette C, Falk R. Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans. Glomerular Disease Collaborative Network. Kidney Int. 51(4), 1188-1195 (1997).
90. Nossent JC. Clinical renal involvement in Afro - Caribbean lupus patients. Lupus 2(3), 173-176 (1993).
91. Alba P, Bento L, Cuadrado MJ et al. Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis. Ann. Rheum. Dis. 62(6), 556-560 (2003).
92. Bastian HM, Roseman JM, McGwin G Jr et al. Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis. Lupus 11 (3), 152-160 (2002).
93. McAlindon T, Giannotta L, Taub N, D'Cruz D, Hughes G. Environmental factors predicting nephritis in systemic lupus erythematosus. Ann. Rheum. Dis. 52(10), 720-724 (1993).
94. Patel M, Clarke AM, Bruce IN, Symmons DP. The prevalence and incidence of biopsy-proven lupus nephritis in the UK: Evidence of an ethnic gradient. Arthritis Rheum. 54(9), 2963-2969 (2006).
95. Seligman VA, Lum RF, Olson JL, Li H, Criswell LA. Demographic differences in the development of lupus nephritis: a retrospective analysis. Am. J. Med. 112(9), 726-729(2002).
96. Bakir AA, Levy PS, Dunea G. The prognosis of lupus nephritis in African - Americans: a retrospective analysis. Am. J. Kidney Dis. 24(2), 159-171 (1994).
97. Barr RG, Seliger S, Appel GB et al. Prognosis in proliferative lupus nephritis: the role of socio-economic status and race/ethnicity. Nephrol. Dial. Transplant. 18(10), 2039-2046 (2003).
98. Contreras G, Lenz O, Pardo V et al. Outcomes in African - Americans and Hispanics with lupus nephritis. Kidney Int. 69(10), 1846-1851 (2006).
99. Contreras G, Pardo V, Cely C et al. Factors associated with poor outcomes in patients with lupus nephritis. Lupus 14(11), 890-895 (2005).
100. Lea JP. Lupus nephritis in African - Americans. Am. J. Med. Sci. 323(2), 85-89 (2002).
101. Adler M, Chambers S, Edwards C, Neild G, Isenberg D. An assessment of renal failure in an SLE cohort with special reference to ethnicity, over a 25-year period. Rheumatology (Oxf.) 45(9), 1144-1147 (2006).
102. Korbet SM, Schwartz MM, Evans J, Lewis EJ. Severe lupus nephritis: racial differences in presentation and outcome. J. Am. Soc. Nephrol. 18(1), 244-254 (2007).
103. Hopkinson ND, Jenkinson C, Muir KR, Doherty M, Powell RJ. Racial group, socioeconomic status, and the development of persistent proteinuria in systemic lupus erythematosus. Ann. Rheum. Dis. 59(2), 116-119 (2000).
104. Salmon JE, Millard S, Schachter LA et al. Fc γ RIIA alleles are heritable risk factors for lupus nephritis in African - Americans. J. Clin. Invest. 97(5), 1348-1354 (1996).
105. Bastian HM, Alarcon GS, Roseman JM et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XL II: factors predictive of new or worsening proteinuria. Rheumatology (Oxf.) (2006).
106. Alarcon GS, Bastian HM, Beasley TM et al. Systemic lupus erythematosus in a multi-ethnic cohort (LUMINA) XXXII: [corrected] contributions of admixture and socioeconomic status to renal involvement. Lupus 15(1), 26-31 (2006).
107. Tejani A, Nicastri AD, Chen CK, Fikrig S, Gurumurthy K. Lupus nephritis in black and Hispanic children. Am. J. Dis. Child. 137(5), 481-483 (1983).
108. Ghaussy NO, Sibbitt W Jr., Bankhurst AD, Qualls CR. The effect of race on disease activity in systemic lupus erythematosus. J. Rheumatol. 31(5), 915-919 (2004).
109. Calvo-Alen J, Vila LM, Reveille JD, Alarcon GS. Effect of ethnicity on disease activity in systemic lupus erythematosus. J. Rheumatol. 32(5), 962-963; author reply 963(2005).
110. Vila LM, Alarcon GS, McGwin G Jr. et al. Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations. Rheumatology (Oxf.) 43(3), 358-363 (2004).
111. Mok CC, Lau CS. Lupus in Hong Kong Chinese. Lupus 12(9), 717-722 (2003).
112. Mok CC, Wong RW, Lau CS. Lupus nephritis in Southern Chinese patients: clinicopathologic findings and long-term outcome. Am. J. Kidney Dis. 34(2), 315-323 (1999).
113. Wang F. Wang CL, Tan CF, Manivasagar M. Systemic lupus erythematosus in Malaysia: a study of 539 patients and comparison of prevalence and disease expression in different racial and gender groups. Lupus 6(3), 248-253 (1997).
114. Johnson SR, Urowitz MB, Ibanez D, Gladman DD. Ethnic variation in disease patterns and health outcomes in systemic lupus erythematosus. J. Rheumatol. 33 (10), 1990-1995(2006).
115. Sutcliffe N, Clarke AE, Gordon C, Farewell V, Isenberg DA. The association of socio-economic status, race, psychosocial factors and outcome in patients with systemic lupus erythematosus. Rheumatology (Oxf.) 38(11), 1130-1137 (1999).
116. Alarcon GS, McGwin G Jr, Petri M et al. Time to renal disease and end-stage renal disease in PROFILE: a multiethnic lupus cohort. PLoS Med. 3(10), E396 (2006).
117. Ward MM, Studenski S. Clinical manifestations of systemic lupus erythematosus. Identification of racial and socioeconomic influences. Arch. Intern. Med. 150(4), 849-853 (1990).
118. Rivest C, Lew RA, Welsing PM et al. Association between clinical factors, socioeconomic status, and organ damage in recent onset systemic lupus erythematosus. J. Rheumatol. 27(3), 680-684 (2000).
119. Yee CS, Hussein H, Skan J et al. Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus. Rheumatology (Oxf.) 42(2), 276-279 (2003).
120. Miertunen PM, Ortiz-Alvarez O, Petty RE et al. Gender and ethnic origin have no effect on longterm outcome of childhood-onset systemic lupus erythematosus. J. Rheumatol. 31(8), 1650-1654 (2004).
121. Zonana-Nacach A, Camargo-Coronel A, Yanez P et al. Measurement of damage in 210 Mexican patients with systemic lupus erythematosus: relationship with disease duration. Lupus 7(2), 119-123 (1998).
122. Toloza SM, Roseman JM, Alarcon GS et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXII. Predictors of time to the occurrence of initial damage. Arthritis Rheum. 50(10), 3177-3186 (2004).
123. Mok CC, Ho CT, Wong RW, Lau CS. Damage accrual in southern Chinese patients with systemic lupus erythematosus. J. Rheumatol. 30(7), 1513-1519 (2003).
124. Uramoto KM, Michet CJ Jr, Thumboo J et al. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum. 42(1), 46-50 (1999).
125. Mok CC, Mak A, Chu WP, To CH, Wong SN. Long-term survival of southern Chinese patients with systemic lupus erythematosus: a prospective study of all age-groups. Medicine (Balt.) 84(4), 218-224 (2005).
126. Urowitz MB, Gladman DD, Abu-Shakra M, Farewell VT. Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24 years. J. Rheumatol. 24(6), 1061-1065 (1997).
127. Health disparities experienced by black or African - Americans - United States. MMWR Morb. Mortal Wkly Rep. 54(1), 1-3 (2005).
128. Wallace DJ, Podell T, Weiner J et al. Systemic lupus erythematosus - survival patterns. Experience with 609 patients. JAMA 245(9), 934-938(1981).
129. Kaslow RA, Masi AT. Age, sex, and race effects on mortality from systemic lupus erythematosus in the United States. Arthritis Rheum. 21(4), 473-479 (1978).
130. Studenski S, Allen NB, Caldwell DS, Rice JR, Polisson RP. Survival in systemic lupus erythematosus. A multivariate analysis of demographic factors. Arthritis Rheum. 30(12), 1326-1332(1987).
131. Ginzler EM, Diamond HS, Weiner M et al. A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis Rheum. 25(6), 601-611 (1982).
132. Ward MM, Pyun E, Studenski S. Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes. Arthritis Rheum. 38(2), 274-283 (1995).
133. Kasitanon N, Magder LS, Petri M. Predictors of survival in systemic lupus erythematosus. Medicine (Balt.) 85(3), 147-156 (2006).
134. Fernandez M, Calvo-Alen J, Andrade R et al. The LUMINA a cohort as a model for the study of ethnic disparities in systemic lupus erythematosus. Arthritis Rheum. (Arthritis Care Res.) In Press (2007).
135. Massardo L, Martinez ME, Jacobelli S et al. Survival of Chilean patients with systemic lupus erythematosus. Semin. Arthritis Rheum. 24(1), 1-11 (1994).
136. Kaslow RA. High rate of death caused by systemic lupus erythematosus; among U. S. residents ofAsian descent. Arthritis Rheum. 25(4), 414-418 (1982).
137. Calvo-Alen J, Alarcon GS, Campbell R Jr. et al. Lack of recording of systemic lupus erythematosus in the death certificates of lupus patients. Rheumatology (Oxf.) 44(9), 1186-1189 (2005).
138. Ward MM. Education level and mortality in systemic lupus erythematosus (SLE): evidence of underascertainment of deaths due to SLE in ethnic minorities with low education levels. Arthritis Rheum. 51(4), 616-624 (2004).